DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice
Authors:
- 8 January 2024
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 373, 114689
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81800514)
- Natural Science Foundation of Zhejiang Province (LBY21H090004)
- Hangzhou Normal University
- National Key Research and Development Program of China (2022YFD1700401, LY19C110001)
This publication has 99 references indexed in Scilit:
- Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION studyDiabetologia, 2021
- Metformin and cognition from the perspectives of sex, age, and diseaseGeroScience, 2020
- TSPO Modulates IL-4-Induced Microglia/Macrophage M2 Polarization via PPAR-γ PathwayJournal of Molecular Neuroscience, 2019
- Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitusActa Diabetologica, 2019
- Microglial repopulation resolves inflammation and promotes brain recovery after injuryGlia, 2017
- Class I Histone Deacetylase Inhibitor Valproic Acid Reverses Cognitive Deficits in a Mouse Model of Septic EncephalopathyNeurochemical Research, 2013
- Role of interleukin‐1β in postoperative cognitive dysfunctionAnnals of Neurology, 2010
- Tissue distribution of the novel DPP‐4 inhibitor BI 1356 is dominated by saturable binding to its target in ratsBiopharmaceutics & Drug Disposition, 2009
- Neurotrophin signaling: many exciting surprises!Cellular and Molecular Life Sciences, 2006
- Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PETNeuroImage, 2002